Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

DaVita

DVA Healthcare Unknown Updated July 31, 2026
$240.04
52W $101.00 – $244.49
49/100
$15.41B
23.7
0.88
AI Committee Verdict
Watch
Conviction: Contested · 43% agreement · 7 analysts
-39.5%
Contested

Is DVA Bullish or Bearish?

Mixed. Innellis AI committee rates DaVita (DVA) Watch with a composite score of 49/100 , based on 7 analysts with 43% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +10.99 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -9.01 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 77.99) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 181.2% shows genuine earnings power backing the valuation — Value
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 101.2x prices in significant intangible value — Value
  • Debt-to-equity of 77.99 adds balance-sheet risk to the value case — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
  • Weekly RSI at 85 -- overbought on the larger timeframe too — Technical
  • High leverage (debt-to-equity 77.99) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
49/100
Agreement
43%
Analysts
7
Conviction
Contested
Sector Rank
Top 93%
of 93 Healthcare peers
Value Analyst neutral
50 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 181.2% shows genuine earnings power backing the valuation
− Price-to-book of 101.2x prices in significant intangible value
Growth Analyst bearish
38 / 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
30 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 77.99) amplifies downside in a stress scenario
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 49.0 to 49.0.

Analyst-level changes:
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • Portfolio Manager: +2 bearish signal(s).
  • Technical Analyst: stance neutral->bullish; score 54->61 (+8).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
66.1
Neutral
MACD Histogram
-0.709
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.89
Inside Bands
Price vs Moving Averages
EMA 9
$237.61 Above
EMA 21
$232.63 Above
EMA 50
$217.41 Above
EMA 200
$173.51 Above

Fundamental Analysis

Valuation
88
Growth
38
Profitability
0
Financial Health
76
Cash Flow
37
Valuation
P/E Ratio 23.7×
P/B Ratio -21.42×
PEG Ratio -12.24
Dividend Yield 0.00%
52W High $244.49
52W Low $101.00
Quality & Growth
ROE -114.7%
ROA 4.3%
Gross Margin 31.1%
Operating Margin 15.0%
Revenue Growth YoY
Debt / Equity -17.50
AI Fundamental Assessment
P/E ratio of 23.7 (inexpensive relative to a 15-40x range); Price-to-book of -21.4x; PEG ratio of -12.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -1.1%; Return on assets of 0.0%; Net margin of 0.1%; Gross margin of 0.3%; Current ratio of 1.42 (tight short-term liquidity); Debt-to-equity of -17.50; Free cash flow margin of 0.7% (thin cash generation); Free cash flow per share is positive (22.15); Most recent quarter beat estimates by 22.6%; 2 consecutive earnings beats; EPS growth decelerating (+66.7% -> -15.6% QoQ); Analyst estimates falling over recent quarters
Get the Full DVA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore DVA Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime